Pubblicazioni
S.C. Oculistica oncologica
2020
- Amaro A, Croce M, Ferrini S, Barisione G, Gualco M, Perri P, Pfeffer U, Jager MJ, Coupland SE, Mosci C, Filaci G, Fabbi M, Queirolo P, Gangemi R. Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition. Cancers (Basel). 2020 Jun 4;12(6):E1468.
- Cunha Rola A, Taktak A, Eleuteri A, Kalirai H, Heimann H, Hussain R, Bonnett LJ, Hill CJ, Traynor M, Jager MJ, Marinkovic M, Luyten GPM, Dogrusöz M, Kilic E, de Klein A, Smit K, van Poppelen NM, Damato BE, Afshar A, Guthoff RF, Scheef BO, Kakkassery V, Saakyan S, Tsygankov A, Mosci C, Ligorio P, Viaggi S, Le Guin CHD, Bornfeld N, Bechrakis NE, Coupland SE. Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study. Cancers (Basel). 2020 Feb 18;12(2):477.
- Mathis T, Maschi C, Mosci C, Espensen CA, Rosier L, Favard C, Tick S, Remignon CH, Ligorio P, Bonin N, Gambrelle J, Nguyen AM, Faber C, Meyer L, Mouriaux F, Herault J, Baillif S, Kiilgaard JF, Kodjikian L, Caujolle JP, Salleron J, Thariat J. COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA. Retina. 2020 May 12 (Epub ahead of print).
2019
- Ciocca M, Magro G, Mastella E, Mairani A, Mirandola A, Molinelli S, Russo S, Vai A, Fiore MR, Mosci C, Valvo F, Via R, Baroni G, Orecchia R. Design and commissioning of the non-dedicated scanning proton beamline for ocular treatment at the synchrotron-based CNAO facility. Med Phys. 2019 Apr;46(4):1852-1862.
- Kenawy N, Kalirai H, Sacco JJ, Lake SL, Heegaard S, Larsen AC, Finger PT,Milman T, Chin K, Mosci C, Lanza F, Moulin A, Schmitt CA, Caujolle JP, Maschi C, Marinkovic M, Taktak AF, Heimann H, Damato BE, Coupland SE. Conjunctival melanomacopy number alterations and correlation with mutation status, tumor features, andclinical outcome. Pigment Cell Melanoma Res. 2019 Jul;32(4):564-575.
- Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, Mosci C, Caujolle JP, Kodjikian L, Thariat J. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019 Jan;68:144-176.
2018
- Patrone S, Maric I, Rutigliani M, Lanza F, Puntoni M, Banelli B, Rancati S, Angelini G, Amaro A, Ligorio P, Defferrari C, Castagnetta M, Bandelloni R, Mosci C, DeCensi A, Romani M, Pfeffer U, Viaggi S, Coviello DA. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Genes Chromosomes Cancer. 2018 Aug;57(8):387-400.
- Thariat J, Rahmi A, Salleron J, Mosci C, Butet B, Maschi C, Lanza F, Lanteri S, Baillif S, Herault J, Mathis T, Caujolle JP. Proton Beam Therapy for Iris Melanomas in 107 Patients. Ophthalmology. 2018 Apr;125(4):606-614.
2016
- Amaro A, Parodi F, Diedrich K, Angelini G, Götz C, Viaggi S, Maric I, CovielloD, Pistillo MP, Morabito A, Mandalà M, Ghiorzo P, Visconti P, Gualco M, AnselmiL, Puzone R, Lanza F, Mosci C, Raggi F, Bosco MC, Varesio L, Zeschnigk M, SpanoL, Queirolo P, Pfeffer U. Analysis of the Expression and Single-NucleotideVariant Frequencies of the Butyrophilin-like 2 Gene in Patients With UvealMelanoma. JAMA Ophthalmol. 2016 Oct 1;134(10):1125-1133.
- Thariat J, Grange JD, Mosci C, Rosier L, Maschi C, Lanza F, Nguyen AM, Jaspart F, Bacin F, Bonnin N, Gaucher D, Sauerwein W, Angellier G, Hérault J, Caujolle JP. Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):328-35.
2015
- Barisione G, Fabbi M, Gino A, Queirolo P, Orgiano L, Spano L, Picasso V, Pfeffer U, Mosci C, Jager MJ, Ferrini S, Gangemi R. Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma. JAMA Ophthalmol. 2015 Jun 11. [Epub ahead of print]
2014
- Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma. Br J Cancer. 2014 Feb 18;110(4):1058-65.
- Gangemi R, Amaro A, Gino A, Barisione G, Fabbi M, Pfeffer U, Brizzolara A, Queirolo P, Salvi S, Boccardo S, Gualco M, Spagnolo F, Jager MJ, Mosci C, Rossello A, Ferrini S. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell Melanoma Res. 2014 Nov;27(6):1138-48.
- Jardel P, Sauerwein W, Olivier T, Bensoussan E, Maschi C, Lanza F, Mosci C, Gastaud L, Angellier G, Marcy PY, Herault J, Caujolle JP, Dendale R, Thariat J. Management of choroidal metastases. Cancer Treat Rev. 2014 Dec;40(10):1119-1128. Review.
- Mosci C, Lanza FB, Mosci S, Barla A. Quantitative echography in primary uveal melanoma treated by proton beam therapy. Can J Ophthalmol. 2014 Feb;49(1):60-5.
2013
- Amaro A, Mirisola V, Angelini G, Musso A, Tosetti F, Esposito AI, Perri P, Lanza F, Nasciuti F, Mosci C, Puzone R, Salvi S, Truini M, Poggi A, Pfeffer U. Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. Eur J Cancer. 2013 Oct;49(15):3353-65.
2012
- Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One. 2012;7(1):e29989.
- Mosci C, Lanza FB, Barla A, Mosci S, Hérault J, Anselmi L, Truini M. Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy. Ophthalmologica. 2012;227(4):190-6.
